A, A., AV, M., C, V., CL, B., A, G., LJ, M., . . . S, P. (2021). Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom. Pharmacoepidemiology and drug safety, 30(2), 237. https://doi.org/10.1002/pds.5150
Chicago Style (17th ed.) CitationA, Arana, et al. "Validation of Cardiovascular Outcomes and Risk Factors in the Clinical Practice Research Datalink in the United Kingdom." Pharmacoepidemiology and Drug Safety 30, no. 2 (2021): 237. https://doi.org/10.1002/pds.5150.
MLA (9th ed.) CitationA, Arana, et al. "Validation of Cardiovascular Outcomes and Risk Factors in the Clinical Practice Research Datalink in the United Kingdom." Pharmacoepidemiology and Drug Safety, vol. 30, no. 2, 2021, p. 237, https://doi.org/10.1002/pds.5150.